Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Serrano

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Journal of Mammary Gland Biology and Neoplasia|November 1, 2003
Breast cancer prevention trials using retinoidsAndrea Decensi, Davide Serrano, Bernardo Bonanni, et al.
Healthcare (Basel, Switzerland)|August 26, 2023
Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast CancerEliza Del Fiol Manna, Davide Serrano, Gaetano Aurilio, et al.
Carcinogenesis|July 24, 2014
Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysisPatrizia Gnagnarella, Elena Pasquali, Davide Serrano, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Pharmacological prevention of breast cancer: quo vadis?Davide Serrano, Bernardo Bonanni, Massimiliano Cazzaniga, et al.
Mutation Research|March 17, 2015
BsmI polymorphism of vitamin D receptor gene and cancer risk: a comprehensive meta-analysisSara Raimondi, Elena Pasquali, Patrizia Gnagnarella, et al.
JNCI Cancer Spectrum|February 8, 2021
Response to BraillonBernardo Bonanni, Davide Serrano, Patrick Maisonneuve, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancerDavide Serrano, Laura Baglietto, Harriet Johansson, et al.
Breast Cancer Research : BCR|October 31, 2012
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drugMatteo Lazzeroni, Davide Serrano, Barbara K Dunn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal WomenDavide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Breast Cancer Research and Treatment|November 13, 2004
Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancerHarriet Johansson, Laura Baglietto, Aliana Guerrieri-Gonzaga, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Journal of Mammary Gland Biology and Neoplasia|November 1, 2003
Breast cancer prevention trials using retinoidsAndrea Decensi, Davide Serrano, Bernardo Bonanni, et al.
Healthcare (Basel, Switzerland)|August 26, 2023
Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast CancerEliza Del Fiol Manna, Davide Serrano, Gaetano Aurilio, et al.
Carcinogenesis|July 24, 2014
Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysisPatrizia Gnagnarella, Elena Pasquali, Davide Serrano, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Pharmacological prevention of breast cancer: quo vadis?Davide Serrano, Bernardo Bonanni, Massimiliano Cazzaniga, et al.
Mutation Research|March 17, 2015
BsmI polymorphism of vitamin D receptor gene and cancer risk: a comprehensive meta-analysisSara Raimondi, Elena Pasquali, Patrizia Gnagnarella, et al.
JNCI Cancer Spectrum|February 8, 2021
Response to BraillonBernardo Bonanni, Davide Serrano, Patrick Maisonneuve, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancerDavide Serrano, Laura Baglietto, Harriet Johansson, et al.
Breast Cancer Research : BCR|October 31, 2012
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drugMatteo Lazzeroni, Davide Serrano, Barbara K Dunn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal WomenDavide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Breast Cancer Research and Treatment|November 13, 2004
Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancerHarriet Johansson, Laura Baglietto, Aliana Guerrieri-Gonzaga, et al.
Pageof 9